Prosecution Insights
Prosecution Insights
13 pending office actions • 10 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (8%) |
| §103 only | 2 (15%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 6 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GIULIANI, GIUSEPPI J | 1 | 57.8% | +6.6% |
| OTT, PATRICK S | 1 | 68.0% | +21.8% |
| AGGARWAL, SAHIL CHANDER | 1 | — | — |
| GONZALEZ, LUISALBERTO | 1 | 61.2% | +44.9% |
| KWAK, DEAN P | 1 | 58.7% | +37.4% |
| JARRELL, NOBLE E | 1 | 80.9% | +9.6% |
| CHONG, YONG SOO | 1 | 43.7% | +41.7% |
| CHHAY, BONIRATH | 1 | 75.0% | +0.0% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| TRAN, KHOA NHAT | 1 | 42.0% | +58.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17940142 | GENERATING AND TESTING HYPOTHESES AND UPDATING A PREDICTIVE MODEL OF PANDEMIC INFECTIONS | CHOI, DAVID | 13d |
| 18035908 | COMPOSITIONS AND METHODS FOR ENHANCING T CELL PENETRATION OF TUMORS AND CANCERS | CHHAY, BONIRATH | 14d |
| 18931500 | Manganese-Nitride Based Novel Magnetic Materials | OTT, PATRICK S | 46d |
| 18437859 | TREATING FIBROSIS WITH A CCK RECEPTOR INHIBITOR | GONZALEZ, LUISALBERTO | — |
| 18682596 | COMBINED DETERMINATION OF THE CONCENTRATION AND ENANTIOMERIC COMPOSITION OF CHIRAL COMPOUNDS USING SINGLE CHIROPTICAL ASSAY | KWAK, DEAN P | — |
| 18290252 | USE OF RAGE INHIBITORS TO TREAT CANCER-RELATED COGNITIVE DECLINE | JARRELL, NOBLE E | — |
| 17921606 | METHODS FOR ISOLATING AND CULTURING TUMOR CELLS | TRAN, KHOA NHAT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18138058 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION | BARSKY, JARED | 89d overdue |
| 18931500 | Manganese-Nitride Based Novel Magnetic Materials | OTT, PATRICK S | 46d |
| 18437859 | TREATING FIBROSIS WITH A CCK RECEPTOR INHIBITOR | GONZALEZ, LUISALBERTO | — |
| 18682596 | COMBINED DETERMINATION OF THE CONCENTRATION AND ENANTIOMERIC COMPOSITION OF CHIRAL COMPOUNDS USING SINGLE CHIROPTICAL ASSAY | KWAK, DEAN P | — |
| 18260721 | USP13 INHIBITORS AND METHODS OF USE THEREOF | CHONG, YONG SOO | — |
| 17921606 | METHODS FOR ISOLATING AND CULTURING TUMOR CELLS | TRAN, KHOA NHAT | — |
| Art Unit | Apps |
|---|---|
| 1628 | 2 |
| 2153 | 1 |
| 1784 | 1 |
| 1624 | 1 |
| 1699 | 1 |
| 1623 | 1 |
| 1645 | 1 |
| 1632 | 1 |
| 1627 | 1 |
| 3684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18938587 | DOCUMENT RETRIEVAL USING INTRA-IMAGE RELATIONSHIPS | GIULIANI, GIUSEPPI J | 2153 | §103 | Final Rejection | 3d overdue | Pending | Nov 06, 2024 |
| 18931500 | Manganese-Nitride Based Novel Magnetic Materials | OTT, PATRICK S | 1784 | §103§112 | Final Rejection | 46d | Pending | Oct 30, 2024 |
| 18743830 | C-KIT INHIBITORS AND USES FOR TREATING AND PREVENTING INFLAMMATORY CONDITIONS | AGGARWAL, SAHIL CHANDER | — | §103§112DP | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18437859 | TREATING FIBROSIS WITH A CCK RECEPTOR INHIBITOR | GONZALEZ, LUISALBERTO | 1624 | §103§112 | Final Rejection | — | Pending | Feb 09, 2024 |
| 18682596 | COMBINED DETERMINATION OF THE CONCENTRATION AND ENANTIOMERIC COMPOSITION OF CHIRAL COMPOUNDS USING SINGLE CHIROPTICAL ASSAY | KWAK, DEAN P | — | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18290252 | USE OF RAGE INHIBITORS TO TREAT CANCER-RELATED COGNITIVE DECLINE | JARRELL, NOBLE E | 1699 | §103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18260721 | USP13 INHIBITORS AND METHODS OF USE THEREOF | CHONG, YONG SOO | 1623 | §102 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18035908 | COMPOSITIONS AND METHODS FOR ENHANCING T CELL PENETRATION OF TUMORS AND CANCERS | CHHAY, BONIRATH | 1645 | §102§103§112Other | Non-Final OA | 14d | Pending | May 08, 2023 |
| 18138058 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION | BARSKY, JARED | 1628 | §103 | Final Rejection | 89d overdue | Pending | Apr 22, 2023 |
| 17921606 | METHODS FOR ISOLATING AND CULTURING TUMOR CELLS | TRAN, KHOA NHAT | 1632 | §103§112 | Final Rejection | — | Pending | Oct 26, 2022 |
| 17919726 | COMBINATION THERAPY OF ARTEMISININ-RELATED COMPOUNDS AND HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF HPV-RELATED BENIGN, PREMALIGNANT, AND MALIGNANT DISEASES | REILLY, SOPHIA JANE | 1627 | §103DP | Final Rejection | 33d | Pending | Oct 18, 2022 |
| 17940142 | GENERATING AND TESTING HYPOTHESES AND UPDATING A PREDICTIVE MODEL OF PANDEMIC INFECTIONS | CHOI, DAVID | 3684 | §101 | Final Rejection | 13d | Pending | Sep 08, 2022 |
| 17659274 | TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS | COPPINS, JANET L | 1628 | §112Other | Final Rejection | 51d overdue | Pending | Apr 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial